Evaluation of Therapeutic Strategy to Prevent Crohn's Disease Endoscopic poSToperatIve recurreNce Based on earlY Dosage of Faecal Calprotectin

NCT06972901 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Crohn Disease (CD)
Ileocolic Resection
Post-endoscopic Operative Reccurence

Interventions

BIOLOGICAL: Early faecal calprotectin dosage

Sponsor

University Hospital, Clermont-Ferrand